Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Allena Pharmaceuticals Inc (NASDAQ: ALNA)

 
ALNA Technical Analysis
5
As on 9th Nov 2022 ALNA STOCK Price closed @ 0.01 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.76 & Strong Sell for SHORT-TERM with Stoploss of 1.12 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ALNASTOCK Price

Open 0.01 Change Price %
High 0.01 1 Day 0.00 0.00
Low 0.01 1 Week 0.00 0.00
Close 0.01 1 Month -0.01 -50.00
Volume 173948 1 Year -1.18 -99.16
52 Week High 1.39 | 52 Week Low 0.01
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
LCID 3.30 3.12%
LMDX 0.02 0.00%
NVDA 139.93 -0.21%
AKTS 0.04 0.00%
OPTT 0.45 36.36%
QSI 2.15 65.38%
TNXP 0.37 -5.13%
TSLA 454.13 -1.76%
PONO 1.72 2.38%
 
NASDAQ USA Top Gainers Stocks
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
MNTSW 0.09 200.00%
GLSPT 33.43 138.62%
BIOC 0.07 133.33%
BCAC 22.71 125.30%
AMPGW 0.90 125.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
CRVL 114.96 -66.91%
TFFP 0.06 -62.50%
MILEW 0.06 -53.85%
MINM 0.15 -51.61%
NVVEW 0.01 -50.00%
 
 
ALNA
Daily Charts		 ALNA
Intraday Charts		 Whats New @
Bazaartrend		 ALNA
Free Analysis
 
ALNA Important Levels Intraday
RESISTANCE0.01
RESISTANCE0.01
RESISTANCE0.01
RESISTANCE0.01
RESISTANCE0.01
RESISTANCE0.01
RESISTANCE0.01
RESISTANCE0.01
 
ALNA Forecast December 2024
Share
4th UP Forecast1.36
3rd UP Forecast0.93
2nd UP Forecast0.66
1st UP Forecast0.39
1st DOWN Forecast-0.37
2nd DOWN Forecast-0.64
3rd DOWN Forecast-0.91
4th DOWN Forecast-1.34
 
ALNA Weekly Forecast
4th UP Forecast0.32
3rd UP Forecast0.22
2nd UP Forecast0.16
1st UP Forecast0.10
1st DOWN Forecast-0.08
2nd DOWN Forecast-0.14
3rd DOWN Forecast-0.20
4th DOWN Forecast-0.30
 
ALNA Forecast2024
4th UP Forecast2.78
3rd UP Forecast1.89
2nd UP Forecast1.34
1st UP Forecast0.79
1st DOWN Forecast-0.77
2nd DOWN Forecast-1.32
3rd DOWN Forecast-1.87
4th DOWN Forecast-2.76
 
 
ALNA Other Details
Segment EQ
Market Capital 68111584.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ALNA Address
ALNA
 
ALNA Latest News
 
Your Comments and Response on Allena Pharmaceuticals Inc
 
ALNA Business Profile
Allena Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, engages in the development and commercialization of oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. The company's lead product candidate is reloxaliase, an oral enzyme therapeutic that is in phase 3 clinical program for the treatment of hyperoxaluria, a metabolic disorder commonly associated with kidney stones in adults. It also develops ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and moderate to severe chronic kidney diseases. Allena Pharmaceuticals, Inc. was incorporated in 2011 and is headquartered in Newton, Massachusetts. Address: One Newton Executive Park, Newton, MA, United States, 02462
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service